Pain Using Reduced Fluence Parameters in Photocoagulation for Diabetic Retinopathy.

Status

Terminated

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00802269

Enrollment

Registered

2008-12-04

Start date

2008-03-31

Completion date

2008-11-30

Last updated

2024-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Proliferative Diabetic Retinopathy

Keywords

Proliferative diabetic retinopathy, Laser photocoagulation, Pain

Brief summary

The used of reduced fluence parameters for panretinal photocoagulation decreases pain as perceived by the patient, compared to traditional parameters.

Interventions

PROCEDURERetinal laser photocoagulation

Retinal laser photocoagulation using a 532 nm laser

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Patients 18 years or older, that signed informed consent * Proliferative diabetic retinopathy with indication for panretinal photocoagulation

Exclusion criteria

* Previous retinal photocoagulation * Previous ocular surgical procedures * Ocular media opacities * History of trigeminal neuralgia * Chronic ocular pain * Depression under conductual or medical treatment

Design outcomes

Primary

Measure	Time frame
Pain (NRS-11 scale)	Immediately post-treatment

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026